Submitted by Anonymous (not verified) on 2 October 2026 - 9:30
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 8, Status: Authorised